Amgen AMGN

  1. All
  2. Commentary
  3. Video Reports
  4. Headlines
    1. Ultimate Stock-Pickers' Top 10 High-Conviction Purchases

      Headlines

      Wed, 18 Feb 2015

      the other four were Actavis ACT, Amgen AMGN , Facebook FB, and Dollar Tree Stores ..... the new purchases of Actavis and Amgen during the quarter. Actavis is a ..... 78.88 0.85 Medium 43,628 1 Amgen AMGN 4 Wide 153.48 0.86 Low 116

    2. Amgen's Biosimilar Headwinds Poised to Increase in 2015, but We're Bullish on Upcoming Launches

      Commentary

      Wed, 28 Jan 2015

      While Amgen 's fourth-quarter results were slightly ..... forecast for 2015 and beyond remains intact. Amgen 's late-stage pipeline is beginning to ..... regulatory in nature. Overall, we think Amgen 's wide moat--built on a diverse portfolio

    3. BRIEF- Amgen sees at least $400 million cost saving in 2015

      Headlines

      Tue, 27 Jan 2015

      Jan 27 (Reuters) - Amgen Inc : * Sees at least $400 million cost saving in 2015 from ongoing restructuring

    4. Amgen profit tops expectations on Enbrel sales, tax credit

      Headlines

      Tue, 27 Jan 2015

      (Reuters) - Amgen Inc on Tuesday reported higher-than-expected fourth-quarter profit, driven by strong sales of its blockbuster rheumatoid arthritis drug Enbrel and a tax credit.

    5. UPDATE 1- Amgen profit tops expectations on Enbrel sales, tax credit

      Headlines

      Tue, 27 Jan 2015

      Jan 27 (Reuters) - Amgen Inc on Tuesday reported higher-than-expected fourth-quarter profit, driven by strong sales of its blockbuster rheumatoid arthritis drug Enbrel and a tax credit.

    6. BRIEF- Amgen Q4 adj shr $2.16

      Headlines

      Tue, 27 Jan 2015

      * Q4 adjusted earnings per share $2.16; q4 gaap earnings per share $1.68; q4 revenue $5.33 billion versus. $5.01 billion

    7. Amgen profit tops expectations on Enbrel sales, tax credit

      Headlines

      Tue, 27 Jan 2015

      Jan 27 (Reuters) - Amgen Inc on Tuesday reported higher-than-expected fourth-quarter profit, driven by strong sales of its blockbuster rheumatoid arthritis drug Enbrel, cost cutting and a tax credit.

    8. Regeneron/Sanofi cholesterol drug gets FDA priority review

      Headlines

      Mon, 26 Jan 2015

      Monday said U.S. health regulators accepted its application to review a potent cholesterol drug on a priority basis, potentially giving it the upper hand in a fierce race with Amgen to bring a new medicine from the promising class to market.

    9. Smead Capital: 4Q 2014 Shareholder Letter

      Headlines

      Thu, 22 Jan 2015

      becomes easy to see where our performance came from Walgreens, Amgen , Disney, Home Depot and Nordstrom were among our best performers. Our poor performers had to fight off popularity ..... America Corp., 4.78% ofBerkshire Hathaway Inc., 4.68% of Amgen Inc., 4.42% of Wells Fargo & Co., 4.40% of Cabela

    10. A Discounted Wide Moat in Biotech

      Video Reports

      Wed, 21 Jan 2015

      One of our favorite biotechs right now is [TICKER: AMGN ] Amgen ( AMGN ). It's trading just recently at about a 15% discount ..... branded versions of. This is something where I think Amgen has a really unique position as someone who has a reputation

      Amgen AMGN found at 0:05

      Karen Andersen: One of our favorite biotechs right now AMGN Amgen ( AMGN ). It's trading just recently at about a 15% discount to our $178 fair value estimate. The firm has a wide moat around
    « Prev12345Next »
    Content Partners